Relevance of cytomegalovirus infection and coronary-artery remodeling in the first year after heart transplantation: A prospective three-dimensional intravascular ultrasound study

Transplantation

Volumn 75, Issue 6, 2003, Pages 839-843

  Potena, Luciano ^a   Grigioni, Francesco ^a   Ortolani, Paolo ^a   Magnani, Gaia ^a   Marrozzini, Cinzia ^a   Falchetti, Elena ^a   Barbieri, Alessandra ^a   Bacchi Reggiani, Letizia ^a   Lazzarotto, Tiziana ^a   Marzocchi, Antonio ^a   Magelli, Carlo ^a   Landini, Maria P ^a   Branzi, Angelo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; GANCICLOVIR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY DISEASE; CYTOMEGALOVIRUS INFECTION; DOSE RESPONSE; FEMALE; FOLLOW UP; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTRAVASCULAR ULTRASOUND; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; AGED; CORONARY ARTERIOSCLEROSIS; CYTOMEGALOVIRUS INFECTIONS; ECHOCARDIOGRAPHY, THREE-DIMENSIONAL; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES;

EID: 0037468671     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000054231.42217.A5     Document Type: Article

References (30)

1. Hosenpud J, Bennet L, Keck B, et al. The registry of the International Society for Heart and Lung Transplantation: seventeenth official report, 2000. J Heart Lung Transplant 2000; 19: 909.
2. Billingham M. Histopathology of graft coronary disease. J Heart Lung Transplant 1992; 11: s38.
3. Rickenbacher P, Pinto F, Lewis N, et al. Prognostic importance of intimal thickness as measured by intracoronary ultrasound after cardiac transplantation. Circulation 1995; 92 (12): 3445.
4. Glagov S, Weisenberg E, Zarins C, et al. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987; 316: 1431.
5. Gibbons G. The pathogenesis of graft vascular disease: implications of vascular remodeling. J Heart Lung Transplant 1995; 14: 149s.
6. Pasterkamp G, Borst C, Post M, et al. Atherosclerotic arterial remodeling in the superficial femoral artery: individual variation in local compensatory enlargement response. Circulation 1996; 93: 1818.
7. Lim T, Liang D, Botas J, et al. Role of compensatory enlargement and shrinkage in transplant coronary artery disease: serial intravascular ultrasound study. Circulation 1997; 95: 855.
8. Pethig K, Heublein B, Meliss R, et al. Volumetric remodeling of the proximal left coronary artery: early versus late after heart transplantation. J Am Coll Cardiol 1999; 34: 197.
9. Kobashigawa J, Wener L, Johnson J, et al. Longitudinal study of vascular remodeling in coronary arteries after heart transplantation. J Heart Lung Transplant 2000; 19: 546.
10. Wong C, Ganz P, Miller L, et al. Role of vascular remodeling of early transplant coronary artery disease: a multicenter prospective intravascular ultrasound study. J Heart Lung Transplant 2001; 20: 385.
11. Potena L, Grigioni F, Magnani G, et al. Increasing plasma homocysteine during follow-up in heart transplant recipients: effect of folate and renal function. Ital Heart J 2000; 1(5): 344.
12. Caforio A, Belloni Fortina A, Piaserico S, et al. Skin cancer in heart transplant recipients: risk factor analysis and relevance of immunosuppressive therapy. Circulation 2000; 102: III222.
13. Mintz G, Nissen S, Anderson W, et al. ACC clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies: a report of the American College of Cardiology task force on Clinical Expert Consensus Documents (Committee to develop a Clinical Expert Consensus Document on standards for acquisition, measurement and reporting of intravascular ultrasound studies [IVUS]). J Am Coll Cardiol 2001; 37: 1478.
14. van der Biji W, Torensma R, Son W, et al. Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leukocytes. J Med Virol 1988; 25: 179.
15. Rubin H. Prevention and treatment of cytomegalovirus disease in heart transplant patients. J Heart Lung Transplant 2000; 19: 731.
16. Vivarelli M, De Ruvo N, Lazzarotto T, et al. Abstention from treatment of low-level pp65 Cytomegalovirus antigenemia after transplantation: a prospective study. Transplantation 2000; 70: 1183.
17. Weis M, Scheidt W. Cardiac allograft vasculopathy: a review. Circulation 1997; 96: 2069.
18. St Goar F, Pinto F, Alderman E, et al. Intracoronary ultrasound in cardiac transplant recipients. In vivo evidence of "angiographically silent" intimal thickening. Circulation 1992; 85(3): 979.
19. Pethig K, Klauss V, Heublein B, et al. Progression of cardiac allograft vascular disease as assessed by serial intravascular ultrasound: correlation to immunological and non-immunological risk factors. Heart 2000; 84(5): 494.
20. Mehra M, Ventura H, Chambers R, et al. Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study. J Am Coll Cardiol 1995; 26: 1537.
21. Kapadia S, Nissen S, Ziada K, et al. Impact of lipid abnormalities in development and progression of transplant coronary disease: a serial intravascular ultrasound study. J Am Coll Cardiol 2001; 38: 206.
22. Koskinen P, Lemstrom K, Bruggeman C, et al. Acute cytomegalovirus infection induces a subendothelial inflammation (endothelialitis) in the allograft vascular wall. Am J Pathol 1994; 144(1): 41.
23. Grattan M, Moreno-Cabral C, Starnes V, et al. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989; 261: 3561.
24. Loebe M, Schuler S, Zais O, et al. Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart. J Heart Lung Transplant 1990; 9: 707.
25. St George K, Rinaldo CJ. Comparison of cytomegalovirus antigenemia and culture assay in patients on and off antiviral therapy. J Med Virol 1999; 59: 91.
26. Gerna G, Percivalle E, Baldanti F, et al. Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patients. New Microbiol 1998; 21: 293.
27. Lemstrom K, Koskinen P, Krogerus L, et al. Cytomegalovirus antigen expression, endothelial cell proliferation, and intimal thickening in rat cardiac allografts after cytomegalovirus infection. Circulation 1995; 92: 2594.
28. Kahl M, Siegel-Axel D, Stengelein S, et al. Efficient lytic infection of human arterial endothelial cells by human cytomegalovirus strains. J Virol 2000; 74: 7628.
29. Arkonak B, Mauk K, Chou S, et al. Low multiplicity cytomegalovirus infection of human aortic smooth muscle cells increases levels of major histocompatibility complex class I antigens and induces a proinflammatory cytokine milieu in the absence of cytopathology. J Heart Lung Transplant 1997; 16: 1034.
30. Wenke K, Meiser B, Thiery J, et al. Simvastatin reduces graft vessel disease and morality after heart transplantation. Circulation 1997; 96: 1398.